This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Fluarix Quadrivalent

GlaxoSmithKline plc

Drug Names(s): GSK2321138A, quadrivalent influenza vaccine, FLU D-QIV, Influsplit Tetra (Germany), Fluarix Tetra (UK)

Description: Fluarix Quadrivalent is a quadrivalent inactivated influenza vaccine (QIV). It contains split virions from 2 type A and two type B influenza strains that are chosen each year by the USPHS based on which influenza strains are expected to be most prevalent.

Fluarix quadrivalent is produced in influenza-infected chicken eggs and contains no adjuvant.


Fluarix Quadrivalent News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug